Skip to main content
. 2019 Feb 1;10(10):1056–1069. doi: 10.18632/oncotarget.26621

Figure 2. Src kinase inhibition increases E-cadherin and β-catenin protein levels in drug-sensitive PDAC cells.

Figure 2

Drug-sensitive (A) and resistant (B) PDAC cells were treated with DMSO or DST (0-1000 nmol/L) for 12 h, lysed, and analyzed by Western blotting with indicated antibodies. Western blots were quantified by densitometric analysis. Values are normalized to β-actin loading control.